chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series; pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series; No adverse reaction; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 IMMUNISATION (pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series), INTERCHANGE OF VACCINE PRODUCTS (pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series) and NO ADVERSE EVENT (No adverse reaction) in a 2-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Comirnaty and Pfizer-BioNTech COVID-19 Vaccine (Three Pfizer maroon cap doses). Past adverse reactions to the above products included No adverse event with Comirnaty and Pfizer-BioNTech COVID-19 Vaccine.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 IMMUNISATION (pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series), INTERCHANGE OF VACCINE PRODUCTS (pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series) and NO ADVERSE EVENT (No adverse reaction). At the time of the report, COVID-19 IMMUNISATION (pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series), INTERCHANGE OF VACCINE PRODUCTS (pediatrician gave a Moderna bivalent booster dose accidently to 2 y/o child after Pfizer's primary series) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.            It was reported that the patient (2-year-old) was accidentally given a Moderna booster by pediatrician after patient completing the Pfizer series. There was three months between her third pfizer dose and the moderna bivalent booster.  Concomitant medications and treatment medications were not reported.
Six days after my Pfizer vaccination #2 on March 25, 2021, I woke up experiencing mild vertigo and nausea. The sensation slowly eased over the next six hours. The next morning Friday, March 26, I woke up again with vertigo but it was worse than the day before. Again over the next 6-8 hours it slowly improved. The next morning, Saturday, March 27,  I woke up again, this time with even more significant vertigo and nausea that did not dissipate through the day. Any head movement at all triggered waves of dizziness and I was unsteady walking. Sunday, March 27, I again woke up with significant vertigo, now with increased tinnitus as well. That afternoon I attempted the Epley maneuver which significantly worsened my vertigo and increased my nausea to the point I vomited about 20 minutes later. I tried sleeping with my head elevated Sunday night. I awoke today (Monday, March 29) with significant vertigo and nausea with tinnitus. My balance is significantly impacted - any head movement at all triggers vertigo and nausea. I am unable to drive - I can just manage to get to the bathroom and back holding on to objects. I attempted to contact my physician this morning and left a message but did not receive a return call
I started having pain in the left arm near vaccine sight, could not lift arm, could not extend arm without pain. Called frozen shoulder by Dr. Some residual pain still in muscle where I got the injection.
It was reported that a female pt received a Fluzone SV '00-'01 vaccination on 11/10/00. Reportedly, about 2 weeks, post vax, the pt developed progressive weakness in legs, pain in back and difficulty walking-dragging right foot. Family physician and Orthopedist saw pt. From folow-up correspondence received on 12/11/2001 states the electormyogram report:findings- Concentric needle EMG studies of selected bilateral lower and left upper extremity as well as bulbar muscles were examined with concentric needle EMG study. there were abundant changes reflecting acute and chronic denervation as well as fasciculation potentials and/or chronic denervation in bilateral lower and left upper extremities. Thoracic paraspinal muscle EMG on the left. Abnormal study consistent with bilater L4-5 radiculopathies. There are chronic and recent changes present. Multi level degenerative disc disease, disc bulding and spondylosis contributing to multi level ventral extradural ridging from C3-4 throught C6-7 as well as foraminal stenosis. Stenotic changes in the canal are present at C5-6 and C6-7. Annular bulges without significant canal compromise. There is mild bilateral neural foraminal encroachment at L4-5.
extreme toe walking, periods of zoning out, loss of speech, grinding teeth, squealing, loss of eye contact, licking objects;all sx occurred w/in 48hr of vax;
3/19/2021  -  Chills, high fever, body aches, shortness of breath, coughing, and headaches. Symptoms have continued to present date ( 4/13/2021).  Taking tylenol, and prescribed medicines.  4/9/2021 - Bright red splochy band around right calf, still having fever, body aches, shortness of breath, coughing, and headaches.
Heart Rate elevated to 120's-150's. Severe pain and tightness when breathing, stabbing stomach pains, nausea, itchy rash/hives to arms and fingers, enlarged and painful lymph nodes axilla of injection arm and neck, fluctuating temp up to 101 F
4/16/10 pt. experiencing chest/back pain, numbness/asymmetry in face, pt. sent to ER Dx with Bells Palsy, the Dx with Guillain Barre Syndrome.
One week post vaccination, developed angioedema of left eye, experienced hives over entire body, tongue itching, scratchy throat, tachycardia
soreness and redness- red patch was at least 3 inches. Consulted with NP on site and told pt to ice and see professional if it gets worse and not better within 24 hours. will give follow up call.
While still in the pharmacy right after the vaccine she started wheezing. Next morning had a low grade temp, left arm  was swollen and lymph nodes in left arm pit was swollen, left breast has a tender lump, terrible headaches and extremely tired. When trying to exercise she is having serve chest pain.  Joint pains in shoulder and neck, muscles has pain and is making a popping sound. Right thyroid is swollen and is getting short of breathe.
Had a massive heart attack; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary series completed, unknown manufacturer), for COVID-19 Immunization. The following information was reported: MYOCARDIAL INFARCTION (death, medically significant), outcome "fatal", described as "Had a massive heart attack". The patient date of death was unknown. Reported cause of death: "Had a massive heart attack". It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Had a massive heart attack
I was 8 weeks pregnant at the time of vaccine. On Friday I started bleeding slightly, by Monday I had a miscarriage. I don't KNOW if this was caused by the vaccine; I just want this event recorded in case it influences future research.
Per translator client died 2 to 3 hrs. after receiving vaccines on 7/2/09. Autopsy is pending to determine cause of death. Due to language barrier unable to get more information.7/21/09-Nancy with Med Exam office called with preliminary COD: Coronary Artery Disease with no other significant conditions contributing to death.  8/13/09 Cause of Death: Coronary artery disease. Manner of death: Natural. Autopsy report summary of findings: I. Atherosclerotic cardiovascular disease. A. Calcific coronary artery disease, marked, involving three major vessels and left main. B. Aortic atherosclerosis, mild to moderate. II. Nephrosclerosis. III. Right rib fractures consistent with resuscitation efforts.
I worked overnight after getting the vaccine. I felt really tired and came home and slept until 3 pm.  When I woke up I had a dull headache and felt crummy.  Decided to sleep the remainder of the day but no fever just was fatigued and had a headache.  My arm was hurting at the injection site but the pain has sense left and the headache is gone also.
bad headache; chills; This is a spontaneous report from a contactable consumer. This consumer reported for a 26-year-old male patient who received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown) on 21Jan2021 at 12:30 PM  via unknown route of administration at single dose (at the age of 26 years old) for covid-19 immunisation. Relevant medical history and concomitant medication were not provided. It was unknown if patientrecived any other vaccines within 4 weeks prior to the COVID vaccine. On unknown date, the patient reported that he got a bad headache at night which has become cyclical. He also got chills every once in a while. The events outcome was unknown. It was unknown if patient received any treatment for events. Since the vaccination, it was unknown if the patient has been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
This spontaneous report was received from a licensed practical nurse, referring to a 21 year old, female patient. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On unknown dates the patient was vaccinated with the three dose series of GARDASIL (dose, route, lot # and expiration date were not reported). Then, on 11-AUG-2015, the patient was vaccinated with an additional dose of GARDASIL 9 by intramuscular route in the left arm (reported as LD), lot # L004014 (expiration date was not reported), because a company representative mistakenly told that it was the Centers for Disease Control and Prevention (CDC) recommendation. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information has been received.
Information has been received from a physician concerning a female patients between 20 - 25 years old who was vaccinated IM with Gardasil. Subsequently all the patient experienced abdominal cramping "like premenstrual related symptoms". Subsequently, all the patient  recovered from abdominal cramping "like premenstrual related symptoms". The patient did not seek medical attention. Additional information has been requested. This is one of several reports from the same source. This is in follow-up to report(s) previously submitted on 7/16/2007.  Initial and follow-up information has been received from a physician and a health professional concernig a 21 year old female patient who on 15-JUN-2007 was vaccinated IM with GARDASIL (lot # 657617/0384U).  On 15-JUN-2007 15 minutes post vaccination, the patient experienced terrible abdominal pain "like premenstrual related symptoms".  On 15-JUN-2007, the patient recovered.  The patient did not seek medical attention.  Alternative diagnosis was incomplete abortion versus dysfunctional uterine bleeding.  Additional information is not expected.  This is one of several reports from the same source.
This spontaneous report as received from a registered nurse refers to a patient of an unknown age and gender. the patient's concurrent conditions, medical history, concomitant therapies, drug reactions or allergies were not provided. On an unknown date in June 2017 (reported as "within last week"), the patient was vaccinated with PNEUMOVAX23 lot # M043424, expiration date June 2018 (strength, dose, route and anatomical location were not provided) for prophylaxis. On an unknown date in June 2017, the patient was diagnosed with cellulitis. The patient sought medical attention and was prescribed unspecified antibiotics. The outcome of the aforementioned event was not provided. No product quality complaint was involved. The causality assessment between the event and PNEUMOVAX23 was not provided. Upon internal review the event cellulitis was considered as medically significant. This is one of two reports received form the same source.; Sender's Comments: US-009507513-1706USA010035:
patient was given flu vaccine before the age of 6 months.  No side effects were noted.
CHEST COLD SINUSITIS Clinical Support 3/19/2021  Center  RN COVID-19 virus infection Dx Medication Infusion Reason for Visit Encounter Notes All notes  Progress Notes from  RN (Internal Medicine) Instructions  COVID 19 Monoclonal Antibody (MAB) Infusion Patient Reference Guide     MAB Infusion Treatment Team:
Pt complained of fatigue, left arm numbness and tingling, muscle aches, arthralgia, joint swelling and 1 cm superficial ecchymosis on upper left deltoid at injection site. Pt was seen by MD on 8/2/00.
Guillain Barre 4/18/08-records received for DOS 11/25-12/07/07- DC DX: Chronic inflammatory demyelinating polyradioneuropathy. Admitted with progressive upper and lower extremity numbness and weakness. Sensory symptoms started about several months ago with burning in her feet. One week duration of numbness with increasing numbness throughout her body and weakness as well in legs. Ten days prior unable to go up or down stairs.  IVIG and Plasmapheresis. PE: absent DTRs. Gait ataxia. Walker use at discharge. Discharged to rehabilitation facility.
Leg cramps/pain, elevated temperature, extreme fatigue, pain at injection site, headache
Patient is currently home overseas. Mother reports via email that son became ill 6/28/04; rushed to hospital and diagnosed with demyelination encephalitis. Patient is still ill, but recovering.
dizziness/lightheaded, migraine, nausea, severe body aches worse than when I had covid
Patient presented to facility with shortness of breath x3 days.. patient came to hospital with worsening symptoms.
The only time I got the flu shot I got the flu. So I'll pass; The only time I got the flu shot I got the flu. So I'll pass; Initial information was received on 03-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media.  This case involves Adult patient (unknown gender) who experienced The only time I got the flu shot I got the flu. So I'll pass (influenza and unevaluable event), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious the only time I got the flu shot I got the flu. So I'll pass (influenza and unevaluable event) (unknown latency) following the administration of INFLUENZA VACCINE. Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment for the event.  It was reported "the only time I got the flu shot I got the flu. So I'll pass".  At time of reporting, the outcome was unknown from the event.  There will be no information available on the batch number for this case.
Wrong dose ordered and administered to patient (0.5ml dose given rather than 0.25ml dose). Discussed with DPH. No adverse effects noted by mother 2 hours later.
Rash on R side of face only. Lymph nodes swollen and tender: R side of face. R jaw tender.
Patient received less than the 0.3mL recommended dose. Specific received amount is unknown. Single dose vial was split between patient and sibling. Patient had no reaction. Parent was notified and will reschedule to receive additional booster dose per Pfizer/CDC recommendation guidelines.
No known adverse events or outcome of administration error. Coding notified me of error. I have been attempting to get ahold of the parent to notify her of error and to assess for adverse reaction.
This case was reported by a consumer via call center representative and described the occurrence of herpes ophthalmic in a 72-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included ACE inhibitors with an associated reaction of anaphylactic reaction. Concurrent medical conditions included implantable defibrillator insertion (in 2005), supraventricular tachycardia and allergy (Penicillin). Concomitant products included Aspirin, Probiotics), vitamin B complex, vitamin D, Calcium, Coreg, Crestor, hydrochlorothiazide, Dyazide, glucosamine, omeprazole, Co Q 10 and verapamil. On 4th May 2018, the patient received the 1st dose of SHINGRIX .5 ml. In May 2018, less than a year after receiving SHINGRIX, the patient experienced blurred vision. On 20th May 2018, the patient experienced herpes ophthalmic (serious criteria GSK medically significant) and eye irritation. On an unknown date, the outcome of the herpes ophthalmic was not recovered/not resolved and the outcome of the eye irritation and blurred vision were unknown. The reporter considered the herpes ophthalmic to be related to SHINGRIX. It was unknown if the reporter considered the eye irritation and blurred vision to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Concomitant medication included multivitamins. After 16 days of vaccination, the patient reported that the she experienced irritation in the right eye while on vaccination and upon return to home, she was seen by ophthalmologist and diagnosed with herpetic infection in that eye. The patient reported that she experienced irritation and blurry vision in the eye, at the time of reporting, as a result as an infection and that it had not responded to antiviral eye drops. The patient reported that the vision had gotten worse since diagnosis. The reporter unable to provide full demographics for the pharmacy or her ophthalmologist. The representative researched the data to saw if there was any similar report. There were no reports. The call center representative taken patient's physician contact for further information, so that he could contact them.
Approximately 5 days (08/12/19) after injection, patient stated she noticed a painful knot at injection site on right arm. Then by day 7 (08/14/19), the knot got harder and developed a blood blister at surface. Patient did not pop or open blister, but it opened and drained on its own during the night while sleeping on day 11. Patient went to provider's office and was seen on day 27 (09/03/19) and told the area was infected. She was prescribed oral cephalexin for 7 days and mupirocin oint for 5 days. Patient will start antibiotic therapy today (09/04/19) and follow up with provider in 7 days if no improvement.
Narrative:  VITAL SIGNS: HR79, BP139/90, RR12, 02 SAT98%(@0930), 5/17/2021 VITAL SIGNS: HR75, BP131/87, RR12, O2SAT98%(@0945), 5/17/2021 D/C AT 0948AM AFTER GIVEN A BOTTLE OF DRINKING WATER.
Information has been received from a 65 year old female consumer with ALLEGRA, household cleaning products, kiwi, nuts, and preservatives in eyes drops allergies, who on 24-APR-2009 was vaccinated with a dose of PNEUMOVAX. Patient did not know if this was her first or second vaccination with PNEUMOVAX. On 24-APR-2009 the patient experienced soreness and swelling at the injection site, the consumer reported that the reaction has moved across her arm and under her arm. She also had injection site hives and heat. The symptoms have responded to BENADRYL and ice. The patient was recovering. The patient sought medical attention through a phone call. Additional information has been requested.
Pfizer Covid-19 orange cap 5-11 year old formulation administered to pt age 4 years 6 months
Low grade fever 6-7 hrs p/vax; couldn't bring below 102 w/tylenol on 2nd day (was up to 103.2R); PT also had runny nose and cough when seen in office 30AUG91;
Right arm red and swollen and itchy, Pt came in to be seen. Benadryl BID X 2 days, Rx: Ice packs applied for swelling. Red papules @site, Possible bug bite.
After patient received the vaccine, she went to wait in the waiting room for 15 minutes. Though after 5 minutes she fainted and a customer helped her to the ground. The patient was very pale and was sweating. We called 911 and the EMT took her to a nearby hospital.
Vaccine given beyond 30 days of refrigeration period; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given beyond 30 days of refrigeration period) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given beyond 30 days of refrigeration period). On 10-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given beyond 30 days of refrigeration period) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was given.  No treatment medication was given. Patient anatomical location was deltoid.   This case was linked to MOD-2021-313106 (Patient Link).
Patient tested positive for 1/23/2022 at home with other positive family members. Patient was admitted to hospital 1/28/2022 testing positive again on 2/1/2022. Paitent was made comfort care by family and wanted to go home with hospice but expired in facility prior to discharge 2/7/2022.
rash on her arms and a little on her legs; This spontaneous case was reported by a patient and describes the occurrence of RASH (rash on her arms and a little on her legs) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 05422A, 939903, 027L20A and 041L20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash on her arms and a little on her legs). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash on legs & arms, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Rash on legs & arms, at an unspecified dose and frequency. At the time of the report, RASH (rash on her arms and a little on her legs) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  It was reported that after the most recent dose the patient had a rash on her arms and a little on her legs. This continued through the summer, but was no longer bothering her at the time of report.